Oncological and surgical outcome after treatment of pelvic sarcomas.

BACKGROUND AND OBJECTIVES:Treatment of pelvic tumors remains challenging due to complex anatomy, poor oncological outcome and high complication rates. We sought to investigate the long-term oncological and surgical outcome of these patients. METHODS:Between 1980 and 2012, 147 patients underwent surg...

Full description

Bibliographic Details
Main Authors: Stephan E Puchner, Philipp T Funovics, Christoph Böhler, Alexandra Kaider, Christoph Stihsen, Gerhard M Hobusch, Joannis Panotopoulos, Reinhard Windhager
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5310872?pdf=render
id doaj-f1d2168adb964f6998c1cec3f66628ba
record_format Article
spelling doaj-f1d2168adb964f6998c1cec3f66628ba2020-11-25T02:48:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01122e017220310.1371/journal.pone.0172203Oncological and surgical outcome after treatment of pelvic sarcomas.Stephan E PuchnerPhilipp T FunovicsChristoph BöhlerAlexandra KaiderChristoph StihsenGerhard M HobuschJoannis PanotopoulosReinhard WindhagerBACKGROUND AND OBJECTIVES:Treatment of pelvic tumors remains challenging due to complex anatomy, poor oncological outcome and high complication rates. We sought to investigate the long-term oncological and surgical outcome of these patients. METHODS:Between 1980 and 2012, 147 patients underwent surgical treatment for pelvic sarcoma. Histological diagnosis was Chondrosarcoma in 54, Ewing's Sarcoma/PNET in 37, Osterosarcoma in 32 and others in 24 patients. Statistical analysis for the evaluation of oncological and surgical outcome was performed by applying Cox proportional hazards regression and Fine-Gray regression models for competing risk (CR) endpoints. RESULTS:The estimated overall survival (OS) to death was 80%, 45% and 37% at 1, 5 and 10 years, respectively. Univariate analyses revealed a statistically significant unadjusted influence of age age (p = 0.038; HR = 1.01), margin (p = 0.043; HR = 0.51) and grade (p = 0.001; HR = 2.27) on OS. Considering the multivariable model, grade (p = 0.005; HR = 3.04) and tumor volume (p = 0.014; HR = 1.18) presented themselves as independent prognostic factors on OS. CR analysis showed a cumulative incidence for major complication of 31% at 5 years. Endoprosthetic reconstruction had a higher risk for experiencing a major complication (p<0.0001) and infection (p = 0.001). CONCLUSIONS:Pelvic resections are still associated with a high incidence of complications. Patients with pelvic reconstruction and high volume tumors are especially at risk. Consequently, a cautious decision-making process is necessary when indicating pelvic reconstruction, although a restrictive approach to pelvic reconstruction is not necessarily reasonable when the other option is major amputation.http://europepmc.org/articles/PMC5310872?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Stephan E Puchner
Philipp T Funovics
Christoph Böhler
Alexandra Kaider
Christoph Stihsen
Gerhard M Hobusch
Joannis Panotopoulos
Reinhard Windhager
spellingShingle Stephan E Puchner
Philipp T Funovics
Christoph Böhler
Alexandra Kaider
Christoph Stihsen
Gerhard M Hobusch
Joannis Panotopoulos
Reinhard Windhager
Oncological and surgical outcome after treatment of pelvic sarcomas.
PLoS ONE
author_facet Stephan E Puchner
Philipp T Funovics
Christoph Böhler
Alexandra Kaider
Christoph Stihsen
Gerhard M Hobusch
Joannis Panotopoulos
Reinhard Windhager
author_sort Stephan E Puchner
title Oncological and surgical outcome after treatment of pelvic sarcomas.
title_short Oncological and surgical outcome after treatment of pelvic sarcomas.
title_full Oncological and surgical outcome after treatment of pelvic sarcomas.
title_fullStr Oncological and surgical outcome after treatment of pelvic sarcomas.
title_full_unstemmed Oncological and surgical outcome after treatment of pelvic sarcomas.
title_sort oncological and surgical outcome after treatment of pelvic sarcomas.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description BACKGROUND AND OBJECTIVES:Treatment of pelvic tumors remains challenging due to complex anatomy, poor oncological outcome and high complication rates. We sought to investigate the long-term oncological and surgical outcome of these patients. METHODS:Between 1980 and 2012, 147 patients underwent surgical treatment for pelvic sarcoma. Histological diagnosis was Chondrosarcoma in 54, Ewing's Sarcoma/PNET in 37, Osterosarcoma in 32 and others in 24 patients. Statistical analysis for the evaluation of oncological and surgical outcome was performed by applying Cox proportional hazards regression and Fine-Gray regression models for competing risk (CR) endpoints. RESULTS:The estimated overall survival (OS) to death was 80%, 45% and 37% at 1, 5 and 10 years, respectively. Univariate analyses revealed a statistically significant unadjusted influence of age age (p = 0.038; HR = 1.01), margin (p = 0.043; HR = 0.51) and grade (p = 0.001; HR = 2.27) on OS. Considering the multivariable model, grade (p = 0.005; HR = 3.04) and tumor volume (p = 0.014; HR = 1.18) presented themselves as independent prognostic factors on OS. CR analysis showed a cumulative incidence for major complication of 31% at 5 years. Endoprosthetic reconstruction had a higher risk for experiencing a major complication (p<0.0001) and infection (p = 0.001). CONCLUSIONS:Pelvic resections are still associated with a high incidence of complications. Patients with pelvic reconstruction and high volume tumors are especially at risk. Consequently, a cautious decision-making process is necessary when indicating pelvic reconstruction, although a restrictive approach to pelvic reconstruction is not necessarily reasonable when the other option is major amputation.
url http://europepmc.org/articles/PMC5310872?pdf=render
work_keys_str_mv AT stephanepuchner oncologicalandsurgicaloutcomeaftertreatmentofpelvicsarcomas
AT philipptfunovics oncologicalandsurgicaloutcomeaftertreatmentofpelvicsarcomas
AT christophbohler oncologicalandsurgicaloutcomeaftertreatmentofpelvicsarcomas
AT alexandrakaider oncologicalandsurgicaloutcomeaftertreatmentofpelvicsarcomas
AT christophstihsen oncologicalandsurgicaloutcomeaftertreatmentofpelvicsarcomas
AT gerhardmhobusch oncologicalandsurgicaloutcomeaftertreatmentofpelvicsarcomas
AT joannispanotopoulos oncologicalandsurgicaloutcomeaftertreatmentofpelvicsarcomas
AT reinhardwindhager oncologicalandsurgicaloutcomeaftertreatmentofpelvicsarcomas
_version_ 1724747009200488448